Large Volume Parenteral Market expected to reach US$15.843 billion by 2030

Large Volume Parenteral Market Trends & Forecast:

The global large-volume parenteral market size is estimated to reach USD 15.843 billion by 2030, registering a CAGR of 5.05% from 2024 to 2030, according to a new report by Knowledge Sourcing Intelligence. The large volume parenteral is a form of aqueous solution, which is usually supplied in volumes of 100 ml and 5,000 ml. The LVP is usually utilized to provide fluid replacement therapy. The global large-volume parenteral market is estimated to attain a greater market share during the forecasted timeline, majorly with the increasing prevalence of chronic diseases across the globe. In the cases of chronic diseases, like cancer, diabetes, and CVD, the LVP products are utilized in administrating medications. Similarly, the growing geriatric population is also estimated to boost the growth of the market during the estimated timeline. With the growing aging population, the diseases related to difficulty in swallowing and digesting oral medication increase. Similarly, the rising elderly population also enhances the need for healthcare needs. The growing demand for biosimilar and biologics are also forecasted to grow the market during the estimated timeline. ? View a sample of the report or purchase the complete study at: Large Volume Parenteral Market

Large Volume Parenteral Market Report Highlights:

 

• The 100 ml - 250 ml parenteral category of the volume segment is estimated to attain greater market share by 2030, as the 100 ml - 250 ml parenteral offers multiple applications, which include basic infusion, correction of electrolytes, and fluid balance distribution among others.
• The rising global demand for large-volume parenteral for nutrition applications, is among the key factors propelling the growth of the market during the estimated timeline. In nutritional applications, LVPs are utilized for full nutritional support and offer various forms of essential nutrients.
• The glass bottle LVP solutions, under the packaging container segment are estimated to attain a greater market share during the forecasted timeline. The glass bottle LVP solutions offer application across nutrition, administrating other drugs, and intravenous infusions among others. The glass bottle LVP solutions are commonly utilized in the admirative sector, majorly as they feature a non-reactive nature.
• The Asia Pacific region is estimated to attain a greater market growth rate, majorly due to the increasing prevalence of chronic diseases in the region. Similarly, the growing advancement in the healthcare sector is also estimated to propel the global large-volume parenteral market in the region.
• North America is anticipated to see steady growth, fueled by advancement in the pharmaceutical and healthcare sectors. The North American region witnessed a major growth in healthcare expenditure and pharmaceutical production, enriching the demand for the large volume of parenteral in the region.

Large Volume Parenteral Market Segmentation:

Knowledge Sourcing Intelligence has segmented the global large-volume parenteral market based on volume, application, packaging container, and region: Large Volume Parenteral Market, By Volume

• 100 ml - 250 ml
• 250 ml - 500 ml
• Above 500 ml

Large Volume Parenteral Market, By Application

• Correction of electrolyte & fluid balance disturbances
• Nutrition
• Vehicle for administering other drugs

Large Volume Parenteral Market, By Packaging Container

• Glass Bottle
• Plastic Bags

Large Volume Parenteral Market, By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE

Large Volume Parenteral Market Key Players:

• Fresenius Kabi AG
• Albert David Ltd.
• Otsuka Holdings Co., Ltd.
• Grifols S.A.
• B. Braun Melsungen AG
• BML Parenteral Drugs
• Akums Drugs & Pharmaceuticals Ltd.
• DJ Labs
• Parenteral Drugs (India) Limited
• BKRS Pharma Pvt. Ltd.
• Pfizer
• Baxter
• August Bioservices
• INCOG BioPharma Services
• Simtra BioPharma Solutions

Global Human Microbiome Market Size Cell Surface Markers Market Report Global Aptamers Market Share